|
CN1293073C
(zh)
|
2001-04-20 |
2007-01-03 |
惠氏公司 |
作为5－羟色胺－6配体的杂环基烷氧基－、－烷硫基－和－烷基氨基吲哚衍生物
|
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
US20030139427A1
(en)
|
2002-08-23 |
2003-07-24 |
Osi Pharmaceuticals Inc. |
Bicyclic pyrimidinyl derivatives and methods of use thereof
|
|
DK1638941T3
(da)
|
2003-05-22 |
2010-10-11 |
Abbott Lab |
Indazol-, benzisoxazol- og benzisothiazolkinaseinhibitorer
|
|
EP1647549A1
(en)
|
2004-10-14 |
2006-04-19 |
Laboratoire Theramex |
Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents
|
|
EP1959926A1
(en)
|
2005-10-25 |
2008-08-27 |
Abbott Laboratories |
Formulation comprising a drug of low water solubility and method of use thereof
|
|
JP2009532375A
(ja)
|
2006-03-30 |
2009-09-10 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
|
EP2068869A4
(en)
*
|
2006-10-06 |
2011-05-25 |
Abbott Lab |
NEW IMIDAZOTHIAZOLE AND IMIDAZOXAZOLE
|
|
JP2009007342A
(ja)
|
2007-06-01 |
2009-01-15 |
Mitsubishi Tanabe Pharma Corp |
医薬組成物
|
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
|
ES2383246T3
(es)
|
2008-06-05 |
2012-06-19 |
Glaxo Group Limited |
4-amino-indazoles
|
|
WO2009147188A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Benzpyrazol derivatives as inhibitors of pi3 kinases
|
|
WO2009147189A1
(en)
|
2008-06-05 |
2009-12-10 |
Glaxo Group Limited |
Novel compounds
|
|
US8653069B2
(en)
|
2008-07-28 |
2014-02-18 |
Jiangsu Hengyi Pharmaceutical Co., Ltd. |
Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia
|
|
TW201107330A
(en)
|
2009-07-31 |
2011-03-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
|
FR2951172B1
(fr)
|
2009-10-13 |
2014-09-26 |
Pf Medicament |
Derives pyrazolopyridines en tant qu'agent anticancereux
|
|
WO2011067365A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Benzpyrazole derivatives as inhibitors of p13 kinases
|
|
WO2011067364A1
(en)
|
2009-12-03 |
2011-06-09 |
Glaxo Group Limited |
Novel compounds
|
|
TW201200518A
(en)
|
2010-03-10 |
2012-01-01 |
Kalypsys Inc |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
|
WO2012061537A2
(en)
|
2010-11-02 |
2012-05-10 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating hair loss disorders
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
US8846712B2
(en)
|
2011-09-12 |
2014-09-30 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013045413A1
(en)
|
2011-09-27 |
2013-04-04 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
US20130102601A1
(en)
|
2011-10-21 |
2013-04-25 |
F. Hoffmann-La Roche Ltd |
Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease
|
|
EP2771340B1
(en)
|
2011-10-25 |
2016-04-13 |
Sanofi |
6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
EP2788000B1
(en)
|
2011-12-06 |
2018-05-30 |
Merck Sharp & Dohme Corp. |
Pyrrolopyrimidines as janus kinase inhibitors
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
DK2830662T3
(da)
|
2012-03-29 |
2019-01-02 |
Univ Columbia |
Fremgangsmåder til behandlng af hårtabsforstyrrelser
|
|
WO2013167403A1
(en)
|
2012-05-09 |
2013-11-14 |
Sanofi |
Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors
|
|
EP2892899B1
(en)
|
2012-09-06 |
2018-03-21 |
Bristol-Myers Squibb Company |
Imidazopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
|
|
TWI629275B
(zh)
|
2013-03-13 |
2018-07-11 |
賽諾菲公司 |
Ｎ－（４－（氮雜吲唑－６－基）－苯基）－磺醯胺及其作為醫藥之用途
|
|
SI3077395T1
(en)
|
2013-12-05 |
2018-03-30 |
Pfizer Inc. |
Pyrrolo(2,3-d)pyrimidinyl, pyrrolo(2,3-b)pyrazinyl and pyrrolo(2,3-d)pyridinyl acrylamides
|
|
EP3097091A1
(en)
|
2014-01-24 |
2016-11-30 |
AbbVie Inc. |
6-phenyl- or 6-(pyridin-3-yl)indazole derivatives and methods of use
|
|
PT3357919T
(pt)
*
|
2014-02-14 |
2020-02-20 |
Respivert Ltd |
Compostos heterocíclicos aromáticos como compostos antiinflamatórios
|
|
KR20170002623A
(ko)
|
2014-05-14 |
2017-01-06 |
화이자 인코포레이티드 |
피라졸로피리딘 및 피라졸로피리미딘
|
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
|
US10519160B2
(en)
|
2014-07-18 |
2019-12-31 |
The General Hospital Corporation |
Imaging agents for neural flux
|
|
WO2016071293A2
(en)
|
2014-11-03 |
2016-05-12 |
Iomet Pharma Ltd |
Pharmaceutical compound
|
|
CN105837574B
(zh)
|
2015-02-02 |
2018-03-02 |
四川大学 |
N‑(3‑哌啶基)‑芳香胺衍生物及其制备方法和用途
|
|
EP3288943B1
(en)
|
2015-05-01 |
2022-09-28 |
Pfizer Inc. |
Pyrrolo[2,3-b]pyrazinyl acrylamides and epoxides thereof as inhibitors of janus kinase
|
|
CA2985185A1
(en)
|
2015-05-07 |
2016-11-10 |
The Trustees Of Columbia University In The City Of New York |
Methods and compositions for promoting hair growth
|
|
WO2017077283A1
(en)
|
2015-11-03 |
2017-05-11 |
Topivert Pharma Limited |
4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as janus kinase inhibitors
|
|
DK3371185T3
(da)
|
2015-11-03 |
2020-11-30 |
Topivert Pharma Ltd |
4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus-kinase-inhibitorer
|
|
US10973913B2
(en)
|
2016-02-16 |
2021-04-13 |
Washington University |
JAK inhibitors and uses thereof
|
|
MX388591B
(es)
|
2016-06-30 |
2025-03-20 |
Daewoong Pharmaceutical Co Ltd |
Derivados de pirazolopirimidina como inhibidor de cinasa.
|
|
WO2018036414A1
(zh)
|
2016-08-23 |
2018-03-01 |
北京诺诚健华医药科技有限公司 |
稠杂环类衍生物、其制备方法及其在医学上的应用
|
|
EP3509572A4
(en)
|
2016-09-08 |
2020-05-13 |
Synergistic Therapeutics, LLC |
TOPICAL FORMULATION FOR HAIR GROWTH
|
|
EP3528816A4
(en)
|
2016-10-21 |
2020-04-08 |
Nimbus Lakshmi, Inc. |
TYK2 INHIBITORS AND USES THEREOF
|
|
US20180117148A1
(en)
|
2016-10-28 |
2018-05-03 |
Andrew J. Holman |
Compounds, pharmaceutical compositions and methods of treatments of immune related diseases and disorders
|
|
WO2018098491A1
(en)
|
2016-11-28 |
2018-05-31 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
KR102398659B1
(ko)
|
2017-03-17 |
2022-05-16 |
주식회사 대웅제약 |
카이네이즈 저해제로서의 피롤로트리아진 유도체
|
|
AU2018312349A1
(en)
*
|
2017-08-01 |
2020-02-06 |
Theravance Biopharma R&D Ip, Llc |
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
|
|
KR102821964B1
(ko)
|
2017-11-03 |
2025-06-19 |
어클라리스 쎄라퓨틱스, 인코포레이티드 |
치환된 피롤로피리미딘 jak 억제제 및 이의 제조 및 사용 방법
|
|
KR102577241B1
(ko)
|
2017-12-28 |
2023-09-11 |
주식회사 대웅제약 |
카이네이즈 저해제로서의 아미노-플루오로피페리딘 유도체
|
|
RU2758370C1
(ru)
|
2017-12-28 |
2021-10-28 |
Даевунг Фармасьютикал Ко., Лтд. |
Производные оксифторпиперидина в качестве ингибитора киназы
|
|
KR102577242B1
(ko)
|
2017-12-28 |
2023-09-11 |
주식회사 대웅제약 |
카이네이즈 저해제로서의 아미노-메틸피페리딘 유도체
|
|
EP3768272B1
(en)
|
2018-03-21 |
2025-07-30 |
Xibin Liao |
Jak inhibitors
|
|
CN113498352A
(zh)
*
|
2019-01-23 |
2021-10-12 |
施万生物制药研发Ip有限责任公司 |
作为jak抑制剂的咪唑并[1,5-a]吡啶、1,2,4-三唑并[4,3-a]吡啶和咪唑并[1,5-a]吡嗪
|